Last reviewed · How we verify

NCT05276648

Efficacy of Erector Spinae Plane Block on Postoperative Delirium in Patients Undergoing Lumbar Spine Surgery

Status unknown NA Last updated 11 March 2022
What this trial tests

NA trial testing CAM ICU test in Postoperative Delirium in 128 participants. Status unknown.

Timeline
1 February 2022
Primary endpoint
1 January 2024
1 February 2024

Quick facts

Lead sponsorAydin Adnan Menderes University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposesupportive care
Enrollment128
Start date1 February 2022
Primary completion1 January 2024
Estimated completion1 February 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Aydin Adnan Menderes University

Who can join

Adults 65 to 99, any sex, with Postoperative Delirium. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Lumbar vertebra surgery is one of the most common surgical procedures.Delirium is common in geriatric patients after lumbar spinae surgery.postoperative delirium usually occurs in the early postoperative period and delays patient mobilization and thus lengthens hospital stay. The aim of this study was to investigate the effect of this field block on postoperative delirium in patients undergoing ESP with lomber vertebra surgery and with ultrasound guidance for postoperative analgesia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Postoperative Delirium

Currently open trials in the same condition.

Other Aydin Adnan Menderes University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05276648.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing